SCHEMBL25251389

SCHEMBL25251389

c1ccc2c(N3CCCC3)nc(NCc3ccc4c(c3)OCO4)nc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX1 Q96LB2 1/20 0.56
GALR2 O43603 1/20 0.56
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
LMNA P02545 3/20 0.54
PDE5A O76074 1/20 0.54
NPC1 O15118 1/20 0.54
RAB9A P51151 1/20 0.54
ALDH1A1 P00352 4/20 0.50
CYP1A2 P05177 4/20 0.50
CYP3A4 P08684 4/20 0.50
CYP2D6 P10635 4/20 0.50
CYP2C19 P33261 3/20 0.50
MAPT P10636 2/20 0.50
HSD17B10 Q99714 2/20 0.50
USP2 O75604 1/20 0.50
CLK4 Q9HAZ1 1/20 0.50
KCNH2 Q12809 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
ALOX15 P16050 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1090790 0.82 MRGPRX1 (0.66) MRGPRX1MEN1KMT2ALMNAALDH1A1
SCHEMBL1090783 0.81 MRGPRX1 (0.65) MRGPRX1MEN1KMT2ALMNAALDH1A1
SCHEMBL1090716 0.81 MRGPRX1 (0.65) MRGPRX1MEN1KMT2ALMNAALDH1A1
SCHEMBL1092285 0.81 MRGPRX1 (0.65) MRGPRX1MEN1KMT2ALMNAALDH1A1
SCHEMBL3637654 0.78 MRGPRX1 (0.61) MRGPRX1MEN1KMT2ALMNAALDH1A1
SCHEMBL3636984 0.78 MRGPRX1 (0.79) MRGPRX1MEN1KMT2ALMNAALDH1A1
SCHEMBL14503122 0.78 GALR2 (0.66) GALR2MEN1KMT2ALMNANPC1
SCHEMBL30455125 0.78 LMNA (0.60) MEN1KMT2ALMNAPDE5ANPC1
Hydrochloric Acid SCHEMBL3643496 0.77 MRGPRX1 (0.77) MRGPRX1MEN1KMT2ALMNAALDH1A1
Hydrochloric Acid SCHEMBL3638859 0.77 MRGPRX1 (0.60) MRGPRX1MEN1KMT2ALMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250051290-A1 NOVEL COMPOUND FOR IMPROVING SLEEP OR USE THEREOF UNIV AJOU IND ACADEMIC COOP FOUND (KR) 2025-02-13 US disclosed
WO-2023121429-A1 NOVEL COMPOUND FOR IMPROVING SLEEP OR USE THEREOF 아주대학교산학협력단 2023-06-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250051290-A1 NOVEL COMPOUND FOR IMPROVING SLEEP OR USE THEREOF ADORA2A, HCRTR1, ADORA1 MRGPRX1 323/4885GALR2 243/4885MEN1 4612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.